223 383

Cited 65 times in

A hierarchical phosphorylation cascade that regulates the timing of PERIOD nuclear entry reveals novel roles for proline-directed kinases and GSK-3beta/SGG in circadian clocks.

Authors
Ko, HW; Kim, EY; Chiu, J; Vanselow, JT; Kramer, A; Edery, I
Citation
The Journal of neuroscience : the official journal of the Society for Neuroscience, 30(38):12664-12675, 2010
Journal Title
The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN
0270-64741529-2401
Abstract
The daily timing of when PERIOD (PER) proteins translocate from the cytoplasm to the nucleus is a critical step in clock mechanisms underpinning circadian rhythms in animals. Numerous lines of evidence indicate that phosphorylation plays a prominent role in regulating various aspects of PER function and metabolism, including changes in its daily stability and subcellular distribution. In this report, we show that phosphorylation of serine 661 (Ser661) by a proline-directed kinase(s) is a key phospho-signal on the Drosophila PER protein (dPER) that regulates the timing of its nuclear accumulation. Mutations that block phosphorylation at Ser661 do not affect dPER stability but delay its nuclear entry in key pacemaker neurons, yielding longer behavioral rhythms. Intriguingly, abolishing phosphorylation at Ser661 also attenuates the extent of dPER hyperphosphorylation in vivo, suggesting the phosphorylated state of Ser661 regulates phosphorylation at other sites on dPER. Indeed, we identify Ser657 as a site that is phosphorylated by the glycogen synthase kinase GSK-3β (SHAGGY; SGG) in a manner dependent on priming at Ser661. Although not as dramatic as mutating Ser661, mutations that abolish phosphorylation at Ser657 also lead to longer behavioral periods, suggesting that a multi-kinase hierarchical phosphorylation module regulates the timing of dPER nuclear entry. Together with evidence in mammalian systems, our findings implicate proline-directed kinases in clock mechanisms and suggest that PER proteins are key downstream targets of lithium therapy, a potent inhibitor of GSK-3β used to treat manic depression, a disorder associated with clock malfunction in humans.
MeSH terms
AnimalsAnimals, Genetically ModifiedBlotting, WesternCell Nucleus/genetics/*metabolismCircadian Rhythm/*physiologyDrosophilaDrosophila Proteins/genetics/*metabolismMotor Activity/physiologyPeriod Circadian Proteins/genetics/*metabolismPhosphorylation/*physiologyProline-Directed Protein Kinases/genetics/*metabolismProtein Transport/physiologyReverse Transcriptase Polymerase Chain ReactionSignal Transduction/*physiology
DOI
10.1523/JNEUROSCI.1586-10.2010
PMID
20861372
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Brain Science
AJOU Authors
김, 은영
Full Text Link
Files in This Item:
12664-12675.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse